20389122|t|Factors affecting survival of patients with neurodegenerative disease.
20389122|a|BACKGROUND: Survival varies widely among different neurodegenerative diseases. Data on the role of the Mini Mental State Examination (MMSE) and apolipoprotein E (APOE) in survival are sparse except for Alzheimer's disease (AD). METHODS: We studied mortality of 3,581 patients in an academic clinic from 1993 to 2004. Average follow-up was 4.1 years. We studied patients with amyotrophic lateral sclerosis (ALS) (n = 174), possible AD (n = 206), probable AD (n = 1,175), Parkinson's disease (PD) (n = 661), mild cognitive impairment (MCI) (n = 357), frontotemporal dementia (FTD) (n = 94), Lewy body disease (LBD) (n = 64), and controls (n = 850). We compared patients' mortality to the US population and to controls. RESULTS: Mortality ranged from 7% for controls to 58% for ALS patients. The median survival times from initial visit for PD, FTD, probable AD, possible AD, LBD, and ALS were 8.9, 7.0, 5.9, 5.6, 5.3, and 2.7 years, respectively. Mortality rate ratios comparing each disease to controls were 39.43, 7.25, 3.70, 3.51, 2.47, 2.73, and 1.61 for ALS, FTD, LBD, PD, probable AD, possible AD, and MCI, respectively. A lower initial MMSE score was associated with higher mortality for probable AD, PD, and MCI, while APOE4 predicted mortality for PD and LBD. Non-whites had 20% lower mortality rates than whites for all dementias combined, adjusting for education. CONCLUSIONS: All neurologic diseases, including MCI, had increased mortality versus controls. A lower MMSE score and APOE4 presence predicted higher mortality for some patient groups.
20389122	30	38	patients	Species	9606
20389122	44	69	neurodegenerative disease	Disease	MESH:D019636
20389122	122	148	neurodegenerative diseases	Disease	MESH:D019636
20389122	215	231	apolipoprotein E	Gene	348
20389122	233	237	APOE	Gene	348
20389122	273	292	Alzheimer's disease	Disease	MESH:D000544
20389122	294	296	AD	Disease	MESH:D000544
20389122	338	346	patients	Species	9606
20389122	432	440	patients	Species	9606
20389122	446	475	amyotrophic lateral sclerosis	Disease	MESH:D000690
20389122	477	480	ALS	Disease	MESH:D000690
20389122	502	504	AD	Disease	MESH:D000544
20389122	525	527	AD	Disease	MESH:D000544
20389122	541	560	Parkinson's disease	Disease	MESH:D010300
20389122	562	564	PD	Disease	MESH:D010300
20389122	582	602	cognitive impairment	Disease	MESH:D003072
20389122	604	607	MCI	Disease	MESH:D060825
20389122	620	643	frontotemporal dementia	Disease	MESH:D057180
20389122	645	648	FTD	Disease	MESH:D057180
20389122	660	677	Lewy body disease	Disease	MESH:D020961
20389122	679	682	LBD	Disease	MESH:D020961
20389122	730	738	patients	Species	9606
20389122	846	849	ALS	Disease	MESH:D000690
20389122	850	858	patients	Species	9606
20389122	909	911	PD	Disease	MESH:D010300
20389122	913	916	FTD	Disease	MESH:D057180
20389122	927	929	AD	Disease	MESH:D000544
20389122	940	942	AD	Disease	MESH:D000544
20389122	944	947	LBD	Disease	MESH:D020961
20389122	953	956	ALS	Disease	MESH:D000690
20389122	1128	1131	ALS	Disease	MESH:D000690
20389122	1133	1136	FTD	Disease	MESH:D057180
20389122	1138	1141	LBD	Disease	MESH:D020961
20389122	1143	1145	PD	Disease	MESH:D010300
20389122	1156	1158	AD	Disease	MESH:D000544
20389122	1169	1171	AD	Disease	MESH:D000544
20389122	1177	1180	MCI	Disease	MESH:D060825
20389122	1273	1275	AD	Disease	MESH:D000544
20389122	1277	1279	PD	Disease	MESH:D010300
20389122	1285	1288	MCI	Disease	MESH:D060825
20389122	1296	1301	APOE4	Gene	348
20389122	1326	1328	PD	Disease	MESH:D010300
20389122	1333	1336	LBD	Disease	MESH:D020961
20389122	1399	1408	dementias	Disease	MESH:D003704
20389122	1461	1480	neurologic diseases	Disease	MESH:D020271
20389122	1492	1495	MCI	Disease	MESH:D060825
20389122	1561	1566	APOE4	Gene	348
20389122	1612	1619	patient	Species	9606
20389122	Association	MESH:D020961	348
20389122	Association	MESH:D010300	348

